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ABSTRACT 
The integrity and function of the periodontium can be compromised by traumatic injuries or 
periodontitis. Currently available clinical therapies are able to stop the progression of 
periodontitis and allow the healing of periodontal tissue. However an optimal strategy capable of 
restoring the anatomy and functionality of the lost periodontal tissue is still to be achieved. 
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Herein is proposed the development of an injectable hydrogel system able to release a growth 
factors and cells to the periodontal defect.  
This injectable system is based on a photocrosslinkable hydrogel, prepared from methacrylated 
Hyaluronic Acid (me-HA) and incorporating Platelet Lysate (PL). The delivery of growth factors 
and cells in situ is expected to enhance regeneration of the periodontium. Various formulations 
of me-HA containing increasing PL concentrations were studied for achieving the formation of 
stable photocrosslinkable hydrogels. The produced hydrogels were subsequently characterized to 
assess mechanical properties, degradation, protein/growth factor release profile, antimicrobial 
activity and response towards human Periodontal Ligament fibroblasts (hPDLFs). The results 
demonstrated that it was possible to obtain stable photocrosslinkable hydrogels incorporating 
different amounts of PL that can be released in a sustained manner. Furthermore, the 
incorporation of PL improved (p<0.02) the viscoelastic properties of the hydrogels and enhanced 
their resilience to the degradation by hyaluronidase (HAase). Additionally, the PL showed to 
provide antimicrobial properties. 
Finally, hPDLFs, either seeded or encapsulated into the developed hydrogels, showed enhanced 
proliferation over time (p<0.05), proportionally to the increasing amounts of PL present in the 
hydrogel formulations. 
 
KEYWORDS 
Photocrosslinkable hydrogels, Platelet lysate, Hyaluronic acid, Periodontal ligament, 
Endogenous regenerative technology 
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INTRODUCTION 
The periodontium is a complex and dynamic oral structure comprising soft and hard tissues, 
the cementum, a functionally oriented periodontal ligament, alveolar bone and gingiva The main 
function of this structure is anchoring the teeth to the jaw bones, while withstands the forces 
originated by the masticatory process
1
. The integrity and function of the periodontium can be 
compromised by trauma or disease, such as periodontitis, an inflammatory disease 
predominantly caused by gram-negative bacteria that causes the destruction of these tooth 
supportive tissues potentially leading to tooth loss
1-2
.  
Current therapeutic options, which include the implantation of autografts, synthetic bone fillers 
and guided tissue regeneration (GTR), are not able to fully regenerate periodontium morphology 
and function. In recent years endogenous regenerative technology (ERT) has arisen as a new 
paradigm in periodontal regeneration. This new concept has its foundations in tissue engineering 
and aims to induce or encourage periodontal regeneration by superimposing specific chemical 
(e.g. growth factors) and biophysical cues
3
. These signals are expected to encourage homing of 
stem and progenitor cells leading to the formation of new periodontal ligament and cementum
3
.  
Platelet rich hemoderivatives (PRHds), namely platelet rich plasma and platelet rich fibrin, 
have been widely investigated for periodontal ERT as important sources of autologous growth 
factors and provisional fibrin matrices
1, 3
. Nevertheless, the traditional PRHds clots retract, 
impairing the needed stability for periodontal tissue ingrowth
4
. In this research work we propose 
the development of photocrosslinkable hyaluronic acid hydrogels enriched with platelet lysate as 
a stable system for the delivery of endogenous GFs, directed for periodontal ERT.  
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It is advocated that current ERT scaffolding materials needs sophistication and that should be 
employed in a patient-tailored fashion using preferably own patients’ biological material
3
. In this 
sense, platelet lysate (PL) offer great potential in regenerative medicine as an alternative source 
of growth factors (GFs)
5-6
. These PL-origin GFs, include fibroblast growth factor (FGF), 
vascular endothelial growth factor, platelet-derived growth factor, transforming growth factors-
β1 and -β2, insulin-like growth factor, epidermal growth factor, epithelial cell growth factor, 
hepatocyte growth factor and bone morphogenetic proteins
7-9
 are known to be involved in 
essential stages of wound healing and regenerative processes such as chemotaxis, cell 
proliferation and differentiation
10-11
. Moreover, platelets release numerous cell adhesion 
molecules (fibrin, fibronectin and vitronectin) which can provide a provisional matrix for the 
adhesion and migration of cells
10
. In addition, platelet concentrates (PCs) have also been 
reported to exhibit antimicrobial properties
12
 and the PL, as a product of PCs activation, is 
expected to have the same antimicrobial properties, contributing for the prophylaxis of the 
wound site. In fact, the use of PL holds several advantages over other (PRHds) which include the 
ease to standardize of the production process and the higher consistency in GF content between 
batches
5
, that is expected to yield more predictable clinical outcomes.  
Since PL is obtained as a liquid solution, it was incorporated in a photocrosslinkable HA 
matrix. HA is a glycosaminoglycan copolymer of D-glucuronic acid and N-acetyl-d-glucosamine 
that is present in connective tissues and plays an important role in several cellular processes 
including, cell proliferation, morphogenesis, inflammation, and wound repair
13
. HA-based 
biomaterials have demonstrated positive results for several potential applications in the 
regeneration of hard or soft tissues
14
. Moreover, given HA anti-inflammatory, anti-edematous, 
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and anti-bacterial effects, it has been also proposed for the treatment of lesions caused by 
periodontal diseases
15-17
.  
The aim is to characterise these PL-rich scaffolds with regard to mechanical properties, release 
of proteins, periodontal cell response and antimicrobial action against dental plaque bacteria. 
This new ERT scaffold offers a new and promising periodontal treatment modality that should 
encourage tissue regeneration through the release of PL-derived GFs while providing 
concomitant anti-microbial action. Furthermore, functionalization of HA with methacrylic 
groups allows the production in situ of stable photopolymerizable hydrogels, enabling the 
application in periodontal defects in a clinical scenario.  
 
MATERIALS AND METHODS 
Materials  
HA obtained from Streptococcus equi (Mw = 1.5 to 1.8 MDa), methacrylic anhydride Irgacure 
2959 (2-hydroxy-4-(2-hydroxyethoxy)-2-methylpropiophenone), hyaluronidase type IV from 
bovine origin (HAase), Phosphate Buffered Saline (PBS), phalloidin-tetramethylrhodamine B 
isothiocyanate 4,6-diamidino-2-phenylindole, dilactate (DAPI) and the dialysis tubing cellulose 
membrane were all purchased from Sigma (Sigma-Aldrich, USA). Sodium hydroxide (NaOH) 
and hydrochloride acid (HCl) were purchased from VWR Chemicals (BDH, Prolabo - 
international, USA). Alpha MEM (α-MEM) culture medium and fetal bovine serum (FBS) were 
purchased from Gibco (Life Technologies, UK). Deuterium oxide (
2
H2O) was purchased from 
LaborSpirit lda (PT) and the polydimethylsiloxane (PDMS) from Down Corning (USA). The 
Muller-Hinton agar plate was obtained from Oxoid (UK). 
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Preparation of Platelet Lysate (PL) 
PL was obtained from different lots of platelet concentrates provided by Serviço de 
Imunohematologia do Centro Hospitalar de São João (CHSJ, Porto, Portugal), based on a 
previously established protocol. To produce PL, batches of platelet concentrates obtained by 
plasma apheresis with a density of 10
6
 cells/µL and biologically qualified according to 
Portuguese legislation (Decreto-Lei No. 100/2011) were processed as previously described
18-19
. 
Very briefly, platelet concentrates from three different donors were pooled and exposed to three 
repeated freezing and thaw cycles (frozen with liquid nitrogen and thawed in a 37°C water bath) 
to promote the lysis of the platelets and release of GFs. Afterwards, the lysis product was 
centrifuged at 1400 rcf for 10 min and the supernatant stored at -20°C until further use
18-19
. 
 
Methacrylation of Hyaluronic Acid (HA) 
The method followed for the methacrylation of HA was based on a previously described 
protocol
20
, (depicted in Figure 1A), consisting in the addition between 5- to 10-fold molar excess 
(5x and 10x) of methacrylic anhydride (MA) to a solution of 1 wt% HA in distilled water 
(dH2O). The pH was adjusted between 8 and 8.5 with 5N NaOH added dropwise. The reaction 
occurred during 24 hours at 4ºC provided by an ice bath. Subsequently, the reaction products 
were precipitated using cold ethanol (at -20ºC). Then the precipitate was dissolved in dH2O and 
dialysed using a membrane with a cut-off of 14,000 kDa for a week against mili-Q water, 
replaced 3 times a day, to remove the unreacted reagents and by-products. Finally, the solution 
was filtered, frozen at -80ºC and the methacrylated HA (me-HA) recovered upon lyophilisation. 
 
Characterization of the me-HA 
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Fourier transform infrared spectroscopy (IR-Prestige-21, FTIR Shimadzu) was used to record 
the infrared spectra of HA and me-HA. Briefly, a small portion of each batch was mixed with 
potassium bromide, and processed into pellets. The spectra were obtained in the range of 400 to 
4000 cm
-1
 at a 4 cm
-1
 resolution with 32 scans. 
1
HNMR spectra were recorded with a Varian 
Inova 500 at 70°C. me-HA solutions were prepared for analysis by dissolving 5 mg of me-HA in 
1 mL of 
2
H2O. The degree of methacrylation (Dmet) was defined as the percentage of 
methacryloyl groups per HA disaccharide repeat unit and was calculated from the ratio of the 
relative peak integration of the methacrylate protons (peaks at ~6.20, ~5.77, and ~2.05 ppm) and 
HA’s methyl protons (~1.98 ppm).  
 
Development of the photocrosslinkable me-HA hydrogels incorporating PL 
The development of the photocrosslinkable me-HA hydrogels incorporating PL was optimized 
by changing the HA (5x and 10x MA molar excess) solution concentration (1 and 2 wt% ), the 
concentration of photoinitiator Irgacure 2959 (0.1 and 0.2 wt/v%), the power of the UV light, the 
distance to the UV light source, and the concentration of PL incorporated in the solvent solution 
(Table 1). PL was incorporated in the solvent solution in increasing volumetric concentrations 
ranging from pure water (0% PL) to pure PL (100% PL). To obtain hydrogels, dry me-HA was 
dissolved in the solvent solution containing the photoinitiator. Then, 25 µL of me-HA solution 
were injected into a circular (5mm diameter) PDMS mold and exposed to a UV light (Omnicure 
series 2000 EXFO S2000-XLA, Omnicure, Canada) to trigger the photocrosslinking, producing 
disk-shaped hydrogels. The produced formulations, incorporating 0, 50 and 100% PL, were 
designated PL0, PL50, and PL100, respectively. 
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Table 1. Summary of the formulations studied for the optimization of the hyaluronic acid 
hydrogels incorporating PL (HAPL). The concentrations of me-HA and Irgacure 2959 are 
presented as weight/volume percentage. The PL concentrations are volumetric concentrations of 
pure PL (100%PL) in water (0%PL). All the formulations described below were prepared using 
both the batches of me-HA (5x and 10x molar excess). 
me-HA 
(wt/v%) 
Irgacure 
(wt/v%) 
PL 
(v/v%) 
1% 
0,10% 
0% 
50% 
100% 
0,20% 
0% 
50% 
100% 
2% 
0,10% 
0% 
50% 
100% 
0,20% 
0% 
50% 
100% 
 
Characterization of the HAPL hydrogels  
Only the 10x me-HA batch allowed obtaining the hydrogels by photopolymerization, using 
either 0.1 or 0.2% of photoinitiator, so this batch was selected for all further studies. Considering 
that Igacure 2959 presents some cytotoxicity
21
, it was also decided to use the lower photoinitiator 
concentration for the following characterization steps. 
 
Evaluation of the mechanical properties by DMA 
The viscoelastic properties of the developed hydrogels (PL0, PL50 and PL100 with 1% or 2% of 
me-HA and with 0.1% of Irgacure) were evaluated by dynamic mechanical analysis (DMA) 
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(TRITEC8000B, Triton Technology, UK), equipped with the compressive mode. DMA spectra 
were obtained during a frequency scan ranging between 0.1 and 15 Hz for all time points. The 
experiments were performed under constant strain amplitude, corresponding to approximately 
1% of the original height of the sample. Samples were tested while immersed in PBS and at 
37°C, to simulate the physiological conditions. 
 
Swelling and weight loss  
The results obtained from the DMA analysis revealed better mechanical properties for the 2% 
me-HA formulation and thus this was selected for the subsequent studies, namely degradation, 
protein release and cell response. Thus, formulations of hydrogels with increasing concentrations 
of PL (PL0, PL50 and PL100), were prepared into disc-shaped samples of 5mm in diameter and 1 
mm thickness, as above described, and placed in 24 wells plate.  
Periodontal ligament fibroblasts express hyaluronidase (HAase) and generate HAase activity 
that regulates extracellular hyaluronan metabolism
22
. Given the presence of this enzyme in the 
periodontium, the degradation promoted by a HAase was investigated. Similar assay was 
conducted in PBS. Each sample was incubated in 1.6 mL of PBS at 37°C, pH 7.4. For the 
enzymatic degradation assays, the same formulations were incubated at 37ºC in 1.6 mL of a 
HAase solution of 100 U/mL in PBS.  
The assays were carried out using 4 samples of each formulation immersed in each of the 
solutions. The samples were retrieved after 1, 3, 7, 14 and 21 days of incubation.  
The wet weight of the samples was registered (PI-214 analytical balance, Denver Instrument 
Company, USA) at each pre-determined time point. The dry weight of the samples was also 
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registered after allowing samples to dry overnight at 37°C. The percentage of weight loss was 
calculated according to equation (1): 
 
Weight	loss =
()

× 100       (Equation 1) 
 
where mi is the initial weight and mf the final weight. 
 
The water uptake ratio was also calculated following equation (2) by dividing each sample wet 
mass (mwet) by the final dry hydrogel mass (mdry). 
 
Water	uptake	ratio =


× 100	      (Equation 2) 
 
Quantification of protein release  
Protein release from PL0, PL50 and PL100 was quantified after 30min, 1h, 4h, 8h, 1, 7, 14 and 
21 days of incubation in PBS at 37°C. For this purpose, at each time point, a volume of 
supernatant was collected and stored at -20°C. The total protein content was quantified using a 
micro BCA protein assay (Thermo Fischer Scientific, USA), following the manufacturer’s 
instructions. Additionally, the release of fibroblast growth factor-2 (FGF-2), present in the PL, 
was also quantified using an enzyme-linked immunosorbent assay kit (Human FGF-basic, 
ELISA Development Kit, by PeproTech, USA), according to manufacturer’s instructions.  
 
Evaluation of the response of human periodontal ligament fibroblasts (hPDLFs)  
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The response of hPDLFs to the photocrosslinked me-HA/PL hydrogels was assessed upon 
either encapsulation or seeding of the cells onto the hydrogels surface and further cultured for up 
to 14days.  
The hPDLFs (ScienCell Research Laboratories) at passage 3 were seeded on disc-shaped (5 
mm diameter) samples of the formulations PL0, PL50 and PL100 produced as previously 
described, at a cell density of 5×10
4 
cm
-2
. A 50 µL drop of a cellular suspension containing 1×10
4
 
cells was seeded on the surface of each sample, previously placed in a 24 wells plate, and 
allowed to adhere for 1h. After this period, 450 µL of α-MEM basal medium (supplemented with 
10% of FBS and 1% antibiotic-antimycotic) were added to each well. The 24 wells plates 
containing the cell-seeded hydrogels were further incubated at 37°C, 5% CO2 for 1, 4, 7 and 14 
days, renewing the culture medium every 3 days. Cells cultured on polystyrene cover-slips 
(Sarstedt) were employed as positive control. 
For the encapsulation, hPDLFs cells were resuspended in 2% me-HA solutions containing 0, 
50 and 100% PL to obtain a final cell density of 4×10
6
 cells.ml
-1
. Then, 25 µL (1×10
5
 cells) of 
the cellular suspension in each hydrogel solution formulation was injected into circular moulds 
(5mm diameter) and exposed to UV light, as previously described to obtain the hydrogel 
samples. The cell-laden hydrogels were subsequently transferred to individual wells of 24-well 
plates, each one containing 500 µL of basal medium. The 24-wells plates were incubated at 
37ºC, 5% CO2 for 1, 4, 7 and 14 days renewing the culture medium every 3 days. 
The metabolic activity of the cells seeded/encapsulated in the hydrogels and further cultured 
was evaluated using the Alamar blue assay (AbDseroTec, USA), following the manufacturer’s 
instructions. Briefly, at each time point, the culture medium was discarded, the samples were 
washed twice with PBS and then incubated in a 10% Alamar blue solution in basal medium (450 
Page 11 of 37
ACS Paragon Plus Environment
ACS Biomaterials Science & Engineering
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 12
µL of basal medium, and 50 µL of Alamar blue) at 37°C, 5% CO2 for 150 min. The fluorescence 
of the supernatant solution was read in triplicates in a microplate reader (Synergy HT, Biotek, 
USA-) at 560 nm of excitation and 590 nm of emission.  
The cellular proliferation was also evaluated as a function of the dsDNA quantification using 
the PicoGreen dsDNA quantification kit, according to manufacturer’s specifications (Life 
Technologies, USA).  
Finally, the morphology and the migration of the cells either encapsulated or seeded on the 
surface of the hydrogels were investigated by confocal microscopy, upon staining with DAPI and 
phalloidin. For this purpose, samples retrieved after each of the pre-set culturing times were 
fixed with 10% formalin (in PBS) for 30 min at room temperature. Afterwards, the samples were 
washed 2 times with PBS to remove the formalin and 300 µL of phalloidin solution (1:100 in 
PBS) were added per well and incubated 1 hour at room temperature. Then phalloidin solution 
was discarded and the samples were washed 3 times with PBS. A DAPI solution (1:1000 in PBS) 
was prepared and 300 µL were added per well and incubated 5 min. The samples were washed 3 
times and the prepared for visualization under a confocal microscopy (TCS SP8 from Leica 
Mycrosystems CMS GmbH) with vectashield mounting medium.  
 
Antimicrobial Assay 
The antimicrobial activity of PL soluble factors released form from the HA hydrogels was 
evaluated using the radial diffusion assay, according to Kirby-Bauer method
23
. Five different 
bacteria species were used: the gram-positive bacteria Bacillus megaterium (Internal collection), 
Methicillin Resistant Staphylococcus aureus (MRSA) (Internal collection), and Vancomycin 
Resistant Staphylococcus aureus (VRSA) (internal collection) and the gram-negative species 
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Pseudomonas aeruginosa T6BT12, Escherichia coli DH5α) and the fungus Candida albicans 
(Internal collection). With the exception of P. aeruginosa, which was isolated from 
environmental samples, all the other microorganisms were isolated from clinical samples. Prior 
to the antimicrobial activity testing, these microorganisms were cultured aerobically in Luria-
Bertani broth at 37 ºC overnight with agitation (150 rpm). Afterwards, they were centrifuged at 
8000 rpm for 5 min, and washed three times with PBS. Microbial cultures were adjusted to a 
concentration corresponding to ca. 10
7
 CFU.mL
-1
, and pipetted with 0.4 % agar into a petri dish 
containing 5 mL of Muller-Hinton (MH) Agar plate.  
The PL0, PL50 and PL100 hydrogels and the negative control (PBS) were placed on MH–agar 
plates and cultured with each of microbial strain at 37 °C for 16 h, upon which the inhibition 
halo measure and the general macroscopic response was recorded. Experiments were performed 
in triplicate. 
 
Statistical analysis 
All the experiments were performed with at least three replicates. All the cell culture 
experiments were performed simultaneously in order to reduce the variability intra-assay and 3 
independent studies were performed, exactly as described. Results are expressed as mean ± 
standard error of the mean (SEM). Statistical analysis was performed by repeated measures Two-
way ANOVA comparison test (* p < 0.05, ** p < 0.01 and *** p<0.001 for statistically 
significant differences) using the software Graph Pad Prism 6. 
 
RESULTS 
Development of the photocrosslinkable me-HA hydrogels 
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HA methacrylation 
In this study, unmodified hyaluronan was methacrylated reacting a 1% HA aqueous solution at 
pH 8, with 5x and 10x of molar excess of MA for 24h at 4ºC.  
The methacrylation of HA was confirmed by the FTIR spectra, where the deep peak at 1715 
cm
-1
 represents the carbonyl ester group resultant from the methacrylation (Figure 1C). 
Moreover, the 
1
HNMR spectra of the me-HA batches (Figure 1D) exhibited the presence the 
characteristic peaks corresponding to the two protons of the double bond region (δ 5.77 and 6.20 
ppm) of the MA group absent in the non-modified HA spectrum. 
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Figure 1. A) Scheme of the methacrylation process of Hyaluronic acid using methacrylic 
anhydride. B) Representative image depicting a typical me-HA/PL hydrogel obtained by 
photopolimerization. C) FTIR Spectra of HA and me-HA produced with 5 and 10x molar excess 
of (5X and 10X me-HA). D) 
1
HNMR spectra of HA, 5x me-HA and 10x me-HA: a) Vynil 
groups of MA (δ 5.77 – 6.20 ppm); b) Methyl group of the N-AcetyL-d-Glucosamine (δ 2.05 
ppm); and c) methyl group of MA (δ 1.94 ppm). 
 
The degree of methacrylation was calculated from the ratio of the relative peak integration of 
the methacrylate protons (peaks at ~6.20, ~5.77, and ~2.05 ppm) and the methyl protons of N-
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Acetyl-D-glucosamine (~1.98 ppm). A Dmet of 14% was obtained for the me-HA batch 
produced with 5x excess of MA (5x me-HA), while the batch produced with 10x excess MA 
(10x me-HA) presented a Dmet of 24%. 
 
Mechanical properties of the developed hydrogels  
Dynamic mechanical analysis (DMA) experiments were performed in a hydrated environment 
at 37ºC, in an array of biologically relevant frequencies, in order to assess the viscoelastic 
properties of the samples in a physiological-like environment. Both storage (elastic) modulus, E’, 
and the loss factor, tan δ, were obtained at different frequencies. E’ is a measure of the materials 
stiffness. The loss factor is the ratio of the amount of energy dissipated (viscous component) 
relative to energy stored (elastic component); tan δ=E’/E”. 
The obtained results (Figure 2) showed the effect of different concentrations of me-HA and/or 
PL on the stiffness of the developed hydrogels. When the concentration of me-HA was increased 
from 1% to 2% the elastic storage modulus of the hydrogels also increased above three to four 
times, from approximately 100 kPa to 428– 600 kPa, in formulations incorporating PL (PL50 and 
PL100). The concentration of PL in the hydrogels also showed to influence the elastic modulus 
that was found to increase proportionally with the amount of PL. The formulation that exhibited 
the highest elastic modulus corresponds to the formulation containing 2% of me-HA dissolved in 
100% PL. 
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Figure 2. Variation of elastic (E’) modulus A) and loss factor (tan δ) B) with frequency of 1% 
and 2% HA hydrogels incorporating 0%,50% and 100% v/v PL (PL0, PL50 and PL100) measured 
by dynamic mechanical analysis. Differences observed on elastic (E’) modulus C) and loss factor 
(tan δ) D) at 1 Hz. * p<0.05, ** p<0.02; *** p<0.001  
 
Degradation behavior 
The weight loss and swelling ratio profiles of the PL0, PL50 and PL100 hydrogels after 
incubation in PBS or HAase (100U/mL) solution at 37ºC for 1, 3, 7 and 14 days are presented in 
Figure 3. 
 
Page 17 of 37
ACS Paragon Plus Environment
ACS Biomaterials Science & Engineering
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 18
 
Figure 3. Weight loss (A and B) and Swelling ratio (C and D) profile of PL0, PL50 and PL100 
hydrogels in: PBS (A and C) and in HAase solution (100U/ ml) (B and D). a) statistically 
different (p<0.05) from PL100; b) statistically different (p<0.05) from PL50; c) statistically 
different (p<0.05) from PL0 and PL50 
 
Weight loss 
Overall, the results obtained showed that the incorporation of PL in me-HA hydrogels 
influences its stability. Although the PL0 hydrogels showed lower weight loss until the 7
th
 day of 
immersion in PBS, they were completely degraded after 14 days (Figure 3A). On the other hand, 
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despite the weight loss profile of the formulations incorporating PL is characterized by an initial 
loss of around 70% of the dry weight in the first 3 days, the PL50 and PL100 hydrogels tend to be 
more stable along immersion time in PBS.  
The weight loss results obtained upon immersion in HAase, revealed that PL100 formulation 
displays higher degradability, upon the first day. Nevertheless, it was found that samples 
containing PL were only completely degraded after 14 days, while all the hydrogels of the PL0 
formulation were completely degraded after only 3 day of immersion in the enzymatic solution. 
 
Swelling ratio 
In the beginning of the assay, the swelling of freshly produced PL100 hydrogels was 
significantly lower than the formulations with lower PL concentration. When immersed in the 
PBS solution the PL0 and PL50 hydrogels, didn't show significant statistical differences among 
them for all the time points studied. Accordingly, both hydrogels formulations presented a 
similar profile characterized by a peak around day 1 (1500% for PL50) and day 3 (1000% for 
PL0), followed by a decrease of swelling until the end of the assay, due to the total degradation of 
the material. On the other hand, PL100 hydrogels had a later peak at day 7, reaching near 1400% 
of swelling. 
Regarding the swelling in HAase solution, the values were statistically similar for PL0, PL50 
and PL100 hydrogels. Nevertheless, while the formulations PL0 and PL50 depicted a similar 
behavior, presenting a constant decrease in the swelling values from the beginning of the assay, 
the PL100 formulation reached an average swelling of 1400% at day 7, before starting to 
decrease. 
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Protein release 
The total amount of protein released from me-HA/PL hydrogels over time is represented in 
Figure 4. 
 
 
Figure 4. Total protein released from the hydrogels containing PL, assessed using the Pierce® 
BCA protein assay kit (A) incubated in PBS. Fibroblasts Growth Factor (FGF) release, assessed 
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using the PeproTech ELISA Development kit (B) incubated in HAase solution (100U/ml). ** 
p<0.02; *** p<0.001 
 
Both PL50 and PL100 hydrogels displayed a similar release profile that is characterized by an 
initial “burst” of protein released during the first hour, that represents around 15% for PL100 
hydrogels and 25% for PL50 hydrogels of the total protein contained, followed by a sustained 
release up to 14 days. While no statistically significant differences were observed between the 
formulations during the first day of release, there was a substantial difference in the amount of 
protein released by the PL100 formulation, which is proportional with the amount of protein 
incorporated in the formulations.  
In order to evaluate the release of PL-specific GFs from the developed HA hydrogels, and the 
interaction of the GFs with the HA mesh, hydrogels were incubated either in PBS or in 100 
U/mL HAase solution and the release products were quantified by ELISA.  
The results for the release of FGF-2, depicted in Figure 4B, showed that the PL50 and PL100 
had a different profile for FGF-2 release. The FGF-2 released by PL50 was characterized by an 
initial burst of release up to day 3, as observed. After day 3, the release kinetics reached an 
apparent plateau, and a slow sustained delivery remained up to day 21. On the other hand, PL100 
hydrogels showed a sustained release, progressing in a linear way, during all the duration of the 
assay, without signs of deceleration. Nevertheless, despite the PL100 hydrogels have higher 
amount of total protein incorporated, they depicted a FGF-2 release similar to the PL50 hydrogel.  
 
Cell response to the developed hydrogels 
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The response of hPDLFs, either surface seeded or encapsulated onto the PL0, PL50 and PL100 
hydrogels was assessed. In both the cases, the increasing amounts of PL in the hydrogels had a 
positive effect in the cells metabolic activity and proliferation rate as shown in Figure 5. 
 
 
Figure 5. Response of hPDLFs seeded/encapsulated on the hydrogels with the formulations PL0, 
PL50, PL100. A) DNA quantification and metabolic activity of encapsulated cells. B) DNA 
quantification and metabolic activity of seeded cell. C) Representative pictures of hPDLFs 
encapsulated in PL50 and PL100 hydrogels, stained with DAPI (Blue) and Phalloidin (Red). for 21 
days. The small micrographs on the bottom left depict the spindle-like shape morphology of the 
hPDLFs encapsulated into the hydrogels. D) hPDLFs seeded on PL50 and PL100 hydrogels and 
cultured for 21 days, stained with DAPI (Blue) and Phalloidin (Red). 
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The results presented in Figure 5A show that there were no significant differences between the 
PL0 and PL50 hydrogels with respect to proliferation and metabolic activity of encapsulated cells. 
Remarkably, PL100 hydrogels exhibited higher cell growth and metabolic activity than PL0 and 
PL50 hydrogels. Regarding the morphology of the encapsulated cells, Figure 5B shows that 
hPDLFs dispersed and stretched inside of the hydrogels, following the alignments of the fibrous 
structures observed macroscopically in the hydrogels. 
The Figure 5C shows the behaviour of the hPDLFs cells when seeded at the surface of the PL0, 
PL50 and PL100 hydrogels. No significant differences were seen in terms of seeding efficiency on 
the hydrogels and on the PS positive control.  
The analysis of hPDLFs distribution throughout the PL-enriched hydrogels, obtained by 
confocal microscopy from PL100 hydrogels 21 days after being seeded on the surface, is 
represented in Figure 6. This picture shows that hPDLFs seeded in the surface of the hydrogels 
migrated up to 70 µm deep into to the hydrogel after 21 days in culture. 
 
 
Figure 6. Three-dimensional reconstruction obtained by confocal microscopy of hPDLFs 
distribution on PL100 hydrogels at day 21 
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Antimicrobial activity  
The antimicrobial effect of PL soluble factors against Pseudomonas aeruginosa, Candida 
albicans, Escherichia Coli, Bacillus megaterium, Staphylococcus (VRSA), and Staphylococcus 
(MRSA), was evaluated. 
The antimicrobial properties of the developed hydrogels containing PL were assessed using the 
agar well diffusion method, adapted from the Kirby-Bauer original method for testing microbial 
resistance to antibiotic drugs. The Figure 7 shows the effect of the hydrogels incorporating 
increasing amounts of PL in the Pseudomonas aeruginosa, Candida albicans, and Escherichia 
coli and e, Bacillus megaterium, vancomycin resistant Staphylococcus aureus (VRSA), 
methicillin resistant Staphylococcus aureus (MRSA).  
The release of PL provides antimicrobial action against methicillin resistant Staphylococcus 
aureus, as shown by the inhibition of growth in the space occupied by the PL100 hydrogel (Figure 
7F). Moreover, it is dependent on the PL content, since no inhibition hallo was observed for the 
formulations with lower amounts of PL incorporated (PL0 and PL50). Nevertheless, despite no 
inhibition halo was observed in the rest of the species for the formulations investigated, no 
degradation or bacterial growth on the hydrogel surface was reported. 
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Figure 7. Antimicrobial assay for PL100 (i) PL50 (ii) and PL0 (iii) formulations where control is 
PBS (iv) using A) Pseudomonas aeruginosa, B) Candida albicans C) Escherichia Coli (E.Coli) 
D) Bacillus megaterium E) Vancomycin resistant Staphylococcus aureus (VRSA) F) Methicillin 
resistant Staphylococcus aureus (MRSA). 
 
DISCUSSION 
The present work describes the development of novel photocrosslinkable hydrogels 
incorporating allogenic platelet lysate, a platelet rich hemoderivative (PRHd), aimed at 
endogenous regenerative technology (ERT) being used for the regeneration of periodontal 
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ligament. PL can be used in clinical applications as an autologous therapy. However, several 
authors 
5, 24
 have reported high donor-to-donor variability in PRHds batches, which could 
correlate with the high variability associated with the clinical outcomes of PRHds treatments 
25
. 
On the other hand, Crespo-Diaz et al. 
5
 reported lower variability in PL batches produced from 
outdated platelet concentrates obtained by plasma apheresis from different donors; therefore 
more predictable therapeutic outcomes could be anticipated. Furthermore, these PL batches were 
shown to be safe of standard pathogens and infectious diseases. In the present work, were used 
outdated (> 5 days old) platelet concentrates obtained by plasma apheresis and biologically 
qualified according to Portuguese legislation (Decreto-Lei No. 100/2011) for blood products 
collection, transport and therapeutic administration. Therefore, these PL batches are expected to 
be as save as any other blood component aimed for therapeutic administration and used in 
allogenic PL-based strategy as proposed. The combination of me-HA with PL, as herein 
proposed, produced a photocrosslinkable system with several advantages for tissue engineering 
applications. Being injectable, these biomaterials can be implanted using minimally invasive 
techniques without requiring surgical interventions. Moreover, the system can fit perfectly to 
irregular shaped defects, deeply interacting with the preserved tissue margins, before being 
photocrosslinked to produce a stable matrix.  
With regard to viscoelastic properties, DMA analysis revealed that these hydrogels exhibit 
elastic modulus ranging from 264±81 kPa for the PL0 formulation to 600±186kPa to the PL100 
formulation (at 1 Hz), comparable to other HA hydrogels incorporating fibrin described for 
artificial cartilage implantation (445kPa)
26
, which support the use of our photocrosslinkable 
hydrogels for soft tissue reconstruction. Moreover, periodontal tissue is continuously subjected 
to very dynamic forces, acting the periodontal ligament as a damper
27-28
. Therefore, the 
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viscoelastic properties displayed by the hydrogels herein developed are of paramount importance 
for periodontal therapy approaches. 
Regarding the degradation of HA hydrogels, it was faster in the presence of the HAase, the 
specific enzymes that degrade the HA in vivo
29
, than in saline solution, as previously reported
13, 
30
. Remarkably, the PL enriched hydrogels remained stable for longer periods. The time to total 
degradation of PL100 was even longer when compared with other HA hydrogels exposed to 
similar conditions
13
. It should be noted that in this study was used a supra-physiologic 
concentration of HAase (100 U/mL), that in human plasma range from 0.0028±0.0004 U/L to 
3.8±0.7 U/L depending on patient health condition
31
. Therefore, these findings suggest that PL-
enriched photocrosslinkable HA hydrogels, may maintain the necessary space stability in vivo 
for new tissue ingrowth
4
. Such reinforcement is attributed to the presence of fibrinogen in the 
PL
1, 18
, as this protein is capable of crosslinking, forming a fibrin mesh which is not susceptible 
to degradation by the HAase. The fibrin/fibrinogen interact specifically with HA for the 
formation of ECM either during wound healing or in normal tissues
32
. This result is in line with 
previous studies in which HA hydrogels incorporating fibrin were proposed for cartilage repair
26
 
given their improved biomechanical properties and the ability to provide an adequate 
environment for cell encapsulation.  
The total PL-proteins release kinetics from the HA hydrogels herein developed was 
characterized by an initial “burst”, followed by a sustained release over time. The release profile 
observed can be explained by two different processes: 1) the fast elution of large amount of the 
soluble proteins that are not physically interacting with the HA mesh, facilitated by the strong 
initial swelling of roughly two times the hydrogel initial weight; 2) a slow release of the proteins 
entrapped in the hydrogel mesh or adherent to the mesh, that are released by the physical 
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degradation of the hydrogel. Since the PL proteins have different isoeletric points (pI), the 
electrostatic interactions and probability of remaining adsorbed to the HA mesh, which are 
negatively charged at physiologic pH, will vary. In this way, the albumin, which is the main 
soluble protein in PL
33
, with an acidic pI (at pH 4.7), is expected to be easily washed out from 
the HA mesh. On the other hand, most of the GFs present in PL with therapeutic interest have 
basic pI (TGF-β at pH 8.90; PDGF-A at pH 9.52; PDGF-B at pH 9.39; VEGF-1 at pH 8.66; 
FGF-2 at pH 9.6). So, they are expected to bind electrostatically to the HA matrix and to the 
insoluble PL proteins to be further released by ion exchange or by the degradation of the HA 
mesh promoted by HAses released for the ECM remodeling promoted during the wound healing 
process. In fact, the release of PL-specific GFs from the photocrosslinkable hydrogels, namely 
FGF-2, was only detected after degradation of the hydrogels in HAase (Figure 4B), while no 
detectable traces of GFs were detected after incubation of the hydrogels in PBS. Studies with 
FGF-2 have shown that this GF upregulate the migration and proliferation of PDL cells
34
. In fact, 
in order to fully regenerate functional of periodontal tissues, several GFs and cytokines should 
interplay in a temporal as spatial controlled manner
10
. Therefore, the controlled release of growth 
factors is a real asset to our hydrogels.  
In line with what has been reported in literature, our findings show that the encapsulation of 
hPDLFs in non-supplemented HA hydrogels (PL0) affects cell proliferation and metabolic 
activity. The biological performance of cells encapsulated in me-HA hydrogels is affected by the 
concentration of the macromer
13, 35
, as well as by the concentration of photoinitiator
35
. 
Furthermore, the exposure to UV radiation was also reported to have adverse effects on viability 
and cell cycle progression, while the differentiation potential remains unchanged
35
. Remarkably, 
the adverse effects of photo-encapsulation were overcome by the incorporation of PL into the 
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hydrogels. The viability and metabolic activity of the encapsulated hPDLFs increased 
proportionally with the incorporation of PL. Previous works have reported the positive effect of 
PL in the proliferation and maintenance of stemness phenotype of human periodontal ligament 
stem cells
36
. In the same line, we observed, in previous works that (hPDLFs) adhere and 
proliferate in genipin-crosslinked PL membranes
37
. It is known that platelets release several 
growth factors, namely PDGF and FGF-2, which have a mitogenic effect over human 
periodontal ligament cells
38-39
. Moreover, PDGF and FGF-2 have been reported to have 
chemotactic properties over hPDLFs
34, 40
, while the adhesion sites provided by the clot-forming 
proteins present in PL should facilitated the inward cell migration observed (Figure 6). 
Therefore, a strategy that can recruit progenitor cells from the preserved periodontal tissue and 
promote their proliferation and maintenance of stemness to colonize the periodontal defect with 
cells with great potential to regenerate periodontal tissue would be a valuable asset for 
periodontal ERT. Hereupon, the first intentional repair promoted by cells originated from 
periodontal tissues could partially restore the primitive anatomy and function of the 
periodontium
4
. 
Finally, we have studied the antimicrobial properties of the developed hydrogels, a very 
important aspect considering the target application. It is known that the main cause of 
periodontal disease, as well as the main factor of rejection for some of the GTR techniques, is 
bacterial infections
41-42
. The HA was previously described to have bacteriostatic properties 
against oral and non-oral bacteria
43
. Carlson et al.
43
 suggested that the bacteriostatic effect of HA 
may be due to the saturation of the bacterial hyaluronate lyase by the excess HA, which prevents 
the bacteria from maintaining elevated levels of tissue permeability and penetrating the physical 
defenses of the host. This would enhance the ability of the host’s immune system to eradicate 
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pathogens. HA molecules in the hydrogels also form a random network of chains that may act as 
a sieve preventing the spread of the bacteria. Platelet concentrate (PC) was previously reported to 
have antimicrobial properties
12
 significantly reducing the growth of methicillin -sensitive or -
resistant Staphylococcus aureus, Group A Streptococcus, and Neisseria gonorrhea, among 
others. Being PL a product of PC activation by freeze/thaw cycles, the same would be expected 
for this hemoderivative. The obtained results in this study meet with the antimicrobial properties 
already described in the literature for platelet concentrates
12
. Here, the methicillin resistant 
Staphylococcus aureus (MRSA) was more susceptible to the hydrogels containing PL100 than the 
other microbial strains tested. Yeaman and Bayer proposed that the bactericidal activity against 
MRSA involved β-lysin, which is responsible for blood clotting found after platelets activation
44-
45
. β-lysin, which is one of the most abundant compound found in PL after activation
46
 has been 
described to act against bacteria cell-wall, rapidly killing and stopping bacteria reproduction
44-45
, 
which could explain the results from this study. In addition, other PL-derived molecules with 
antibacterial properties against Gram+ bacteria could be involved in this response, such as 
neutrophil activating protein-2 demonstrated capacity to kill Gram-positive and Gram-negative 
bacteria
47-48
. Although no effect was observed against Gram- bacteria and fungus, other factors 
can be found in PL with bactericidal and fungicidal activity. For instance, Platelet factor-4 can 
bind to Gram-negative bacteria since it has an affinity for the lipopolysaccharide from these 
bacteria, facilitating their clearance
49-50
. Nevertheless, further investigation is needed in order to 
fully understand PL antimicrobial properties against microbial pathogens, especially whether the 
molecules that demonstrate antimicrobial potential interact alone or together when supplemented 
as PL and not from induced platelets.  
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CONCLUSIONS 
Overall, our findings demonstrate that is possible to obtain versatile photocrosslinkable HA-PL 
hydrogels that provide adequate substrates for hPDLFs attachment and growth while enabling 
the sustained release of PL and inhibit bacterial growth. Besides providing adequate space and 
stability, as well as biochemical cues for the regeneration of the lost tissues the hydrogels 
developed in this study present antimicrobial properties, which can contribute for the 
prophylaxis, preventing recurrent microbiotic colonization of the periodontal wound. These 
results suggest the great potential of these materials as cell and/or autologous growth factors 
carriers for endogenous regenerative technology (ERT) envisioning tissue engineering 
approaches targeting various tissues, namely the periodontal ligament. 
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ABBREVIATIONS 
PL, Platelet Lysate; hPDLFs, human Periodontal Ligament fibroblasts; GTR, guided tissue 
regeneration; HAase, hyaluronidase; ERT, endogenous regenerative technology; MRSA, 
Methicillin Resistant Staphylococcus aureus; VRSA, Vancomycin Resistant Staphylococcus 
aureus; HA, hyaluronic acid; me-HA, methacrylated hyaluronic acid; GFs, growth factors; α-
MEM, minimum essential medium eagle alpha modification; PDMS, polydimethylsiloxane; MA, 
methacrylic anhydride; dH2O, distilled water; FTIR, fourier transform infrared spectroscopy; 
1
HNMR, Proton nuclear magnetic resonance; Dmet, degree of methacrylation; PL0, hydrogel 
incorporating 0 v/v% of PL; PL50, hydrogel incorporating 50 v/v% of PL; PL100, hydrogel 
incorporating 100 v/v% of PL; HAPL, hyaluronic acid hydrogels incorporating PL; mwet, 
hydrogel wet mass; mdry, dry hydrogel mass; mi, initial weight; mf, final weight; ELISA, 
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Enzyme-Linked Immunosorbent Assay; FGF-2, fibroblast growth factor-2; MH, Muller-Hinton 
(agar); DMA, dynamic mechanical analysis, pI, isoelectric point. 
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